Briefs: Natco Pharma and Panacea Biotec

Briefs: Natco Pharma and Panacea Biotec

By: IPP Bureau

Last updated : June 16, 2023 10:12 am



Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products


Natco Pharma receives EIR from USFDA for Vizag facility

Natco Pharma Limited has announced the successful closure of inspection and received Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) for its drug formulations manufacturing facility at Visakhapatnam (Vizag), Andhra Pradesh, India, for an inspection conducted during the period from 30th January to 3rd February 2023.

Panacea Biotec launches new range of pediatric food and nutritional products in India

Panacea Biotec Limited, one of India's leading biotechnology company, has announced the launch of its new range of high-quality pediatric food & nutritional products ChilRun, ChilRun Full, ChilRun No Sucrose, ChilRun 7+ in different flavours and sizes in India by its wholly owned subsidiary, Panacea Biotec Pharma Limited.

Natco Pharma Panacea Biotec

First Published : June 16, 2023 12:00 am